Qlife Holding
0,001 SEK −20%HC Andersen Capital on aikaisemmin saanut maksun yhtiöltä Qlife Holding DigitalIR/Corporate Visibility -sopimuksesta. Tämä tarkoittaa, että sivulta voi löytyä maksettua materiaalia, jota ei ole päivitetty. Katso vastuuvapauslauseke.
Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology. The Danish-based company is listed on Nasdaq First North Stockholm.
Lue lisääViimeisimmät analyysit
Analyst
![Claus Thestrup Claus Thestrup](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/637ef734-dcbf-426c-bf91-0ac4a79aa71e.png)
![Henrik Ekman Henrik Ekman](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/6e03ef5d-f5bb-4113-a20b-1a7d036027c4.png)
Viimeisimmät videot
Pörssikalenteri
Suurimmat omistajatLähde: Millistream Market Data AB
Omistaja | Osuus | Ääniä |
---|---|---|
Trådgårdshuset Nissarna AB | 7,8 % | 7,8 % |
Försäkringsbolaget Avanza Pension | 6,6 % | 6,6 % |
Inderes Premium
Tämä sisältö on vain Inderes Premium -käyttäjille.
Qlife Holding AB loses arbitration proceedings against Aidian
Qlife Holding AB publishes information by reason of ongoing negotiations with Atlas Special Opportunities, LLC, regarding a financing solution
Liity Inderesin yhteisöön
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
FREE-tili
PREMIUM-tili
Qlife Holding AB: The exercise period for warrants series TO 4 in Qlife Holding begins today
Qlife Holding AB publishes 2023 annual report
Qlife Holding AB: Qlife starts clinical trial in China with first biomarker on Egoo Health
Qlife Holding AB: QLIFE HOLDING AB, Interim Report Q1, January to March 2024
Kallelse till årsstämma 2024 i Qlife Holding AB
Qlife Holding AB enters into an addendum with the holders of the company's convertible debentures and all outstanding convertible debentures are converted into shares
Bulletin from the extraordinary general meeting, and the first meeting for liquidation purposes, in Qlife Holding AB on 23 April 2024
Qlife Holding AB: CORRECTION Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure
Qlife Holding AB: Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure
Qlife Holding AB: Qlife announces the last day for trading in BTU and the first day for trading in warrants series TO 4 and TO 5
Qlife Holding AB: UPDATE: Qlife is emphasizing its strategy to finalize regulatory and Go-To-Market in China, register in Asian countries through partners, and then file for approval in the UK and EU
Qlife Holding AB: Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships
Notice of extraordinary general meeting, and the first meeting for liquidation purposes, in Qlife Holding AB
Qlife Holding AB: UPDATE: Qlife is emphasizing that the call today for an extraordinary general meeting (EGM) is a necessity according to Swedish law, but that the company otherwise is following its plans.
Qlife Holding AB: Qlife has prepared a balance sheet for liquidation purposes and the board of directors will convene an extraordinary general meeting (for liquidation purposes)
![HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/06aef4ac-f94b-407d-ac4d-dffe67b0f7a5.png)
HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.
![Qlife Holding: Interview with Marketing Manager from Egoo Health(Qlife Brand) Christopher Lee Dahm](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/b7d83f94-f596-470a-909e-92455d4fe831.png)